repotrectinib 160 MG Oral Capsule [Augtyro]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
repotrectinib 160 MG Oral Capsule [Augtyro]
160 MG · Oral Capsule · oral
A form of repotrectinib →
repotrectinib 160 MG Oral Capsule [Augtyro] — Other protein kinase inhibitors. Strength, form, class, interactions & more.
![repotrectinib 160 MG Oral Capsule [Augtyro]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fb526827-40ba-4462-94cf-179ae3b0cb8a&name=Augtyro+160+mg_2.PNG.jpg)
Active ingredient
Classification
Other protein kinase inhibitorsKinase Inhibitor
Drug interactions
Repotrectinib has several significant drug interactions that should be avoided to prevent adverse effects and reduced efficacy.
- majorstrong and moderate CYP3A inhibitors — increased repotrectinib exposure and adverse reactions
- majorP-gp inhibitors — increased repotrectinib exposure and adverse reactions
- majorstrong and moderate CYP3A inducers — decreased repotrectinib plasma concentrations and efficacy
- majorcertain CYP3A4 substrates — reduced efficacy of CYP3A4 substrates
- majorhormonal contraceptives — reduced effectiveness of hormonal contraceptives
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication